Your browser doesn't support javascript.
Development of a Handheld Nano-centrifugal Device for Visual Virus Detection.
Bi, Zi-Rong; Hu, Meng-Lu; Jiang, Yong-Zhong; Xiong, Er-Hu; Shu, Bo-Wen; Li, Si-Qi; Chen, Han-Wei; Chen, Xiao-Hua; Zhou, Xiao-Ming.
  • Bi ZR; South China Normal University-Panyu Central Hospital Joint Laboratory of Basic and Translational Medical Research, Guangzhou Panyu Central Hospital, Guangzhou, 511400 China.
  • Hu ML; School of Life Sciences, South China Normal University, Guangzhou, 510631 China.
  • Jiang YZ; School of Life Sciences, South China Normal University, Guangzhou, 510631 China.
  • Xiong EH; Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079 China.
  • Shu BW; School of Life Sciences, South China Normal University, Guangzhou, 510631 China.
  • Li SQ; Dermatology Hospital, Southern Medical University, Guangzhou, 510091 China.
  • Chen HW; Department of Ultrasound, Panyu Central Hospital, Guangzhou, 511400 China.
  • Chen XH; South China Normal University-Panyu Central Hospital Joint Laboratory of Basic and Translational Medical Research, Guangzhou Panyu Central Hospital, Guangzhou, 511400 China.
  • Zhou XM; Medical Imaging Institute of Panyu, Guangzhou, 511400 China.
J Anal Test ; 6(4): 353-364, 2022.
Article in English | MEDLINE | ID: covidwho-1982424
ABSTRACT
Gold nanoparticles (AuNPs) colorimetric assays based on distance-dependent optical characteristics have been widely employed for bioanalysis. However, this assay is not effective for visually detecting low-concentration targets due to the faint color change. Here, we developed a handheld nano-centrifugal device which could separate the crosslinked and non-crosslinked AuNPs. Results showed that the handheld nano-centrifugal device could easily reach more than 6000 r/min within 10 s simply by stretching and tightening the coiled rope in an appropriate rhythm. Further, combined with the CRISPR/Cas12a nucleic acids recognition system, a field-deployable colorimetric platform termed handheld nano-centrifugal device assisted CRISPR/Cas12a (Hand-CRISPR) has been validated. Moreover, clinical diagnostics applications for Epstein-Barr virus (EBV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detection with high sensitivity and accuracy (100% consistency with reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) test results) have been demonstrated. Overall, the Hand-CRISPR platform showed great promise in point-of-care-test (POCT) application, expected to become a powerful supplement to the standard nucleic acid testing method in remote or poverty-stricken areas. Supplementary Information The online version contains supplementary material available at 10.1007/s41664-022-00232-0.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Prognostic study Language: English Journal: J Anal Test Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Prognostic study Language: English Journal: J Anal Test Year: 2022 Document Type: Article